August 2024 Newsletter
An Introduction to Psilocybin Therapy in the United States
September 2024 Newsletter
Ketamine in Mental Health: Addressing the Urgent Need for Skilled, Ethical Therapist Training
Fluence Announces Free Webinar on FDA’s MDMA-Assisted Therapy Decision
Fluence and Reunion Neuroscience Inc. Partners on RE104 Phase 2 in PPD
Announcing the Certificate in Psychedelic Therapy and Integration
Oregon’s first psilocybin treatment center receives license, will start serving clients this month
Meet Oregon’s first psilocybin therapy facilitators
Could Psychedelics Revolutionize Addiction Treatment?
